{
    "title": "106_s2501",
    "content": "The \"Generic Pharmaceutical Access and Choice for Consumers Act of 2000\" encourages the use of generic drugs in various healthcare programs, including the Public Health Service Act, Federal employees health benefits program, Medicare program, Medicaid program, Indian Health Service, veterans programs, uniformed services health care, and Federal prisoners. Therapeutic equivalence requirements for generic drugs are also addressed in the Act. Sec. 201 of the \"Generic Pharmaceutical Access and Choice for Consumers Act of 2000\" focuses on the therapeutic equivalence of generic drugs. It is part of Title III which addresses generic pharmaceuticals and Medicare reform. Congress finds that generic pharmaceuticals are therapeutically equivalent to brand-name drugs, providing consumers with a safe and cost-effective alternative. The market has become more competitive due to the increased availability of generics, leading to significant cost savings estimated between $8-10 billion annually. Generic pharmaceuticals cost significantly less than brand-name drugs, saving an estimated $15 to $30 per prescription. The market share of generic drugs has more than doubled in the last decade, from 19% to 43%. The Act aims to reduce prescription drug costs for the government and beneficiaries of Federal health care programs while maintaining quality healthcare. The Act aims to reduce prescription drug costs for government health care programs by promoting the use of generic drugs and ensuring they are considered therapeutically equivalent to brand-name drugs. TITLE I--ENCOURAGEMENT OF THE USE OF GENERIC DRUGS\n\nSEC. 101. ENCOURAGEMENT OF THE USE OF GENERIC DRUGS UNDER THE PUBLIC HEALTH SERVICE ACT. Part B of title II of the Public Health Service Act is amended to encourage the use of generic drugs. Under this Act, grants or contracts for healthcare services must prioritize generic drug prescriptions unless specifically ordered by the provider or requested by the individual. The term 'generic form of the drug' refers to drugs approved as therapeutic equivalents under the Federal Food, Drug, and Cosmetic Act. The amendment under section 505(j)(5)(E) of the Act defines 'nongeneric form of the drug' as a drug approved under section 505(b) of the Federal Food, Drug, and Cosmetic Act. This amendment applies to drugs provided after the Act's enactment date. SEC. 102 amends Section 8902 of title 5, United States Code, to require carriers to provide, pay, or reimburse the cost of generic drugs unless the nongeneric form is specifically ordered by the provider or requested by the individual. The effective date is for contract years beginning on or after January 1, 2001. The Social Security Act is amended to define drugs as generic unless specifically ordered by the provider or requested by the individual. The amendment applies to drugs furnished after the enactment date, with an exception for Medicare+Choice plans. The amendment to the Social Security Act defines drugs as generic unless specified otherwise, with an exception for Medicare+Choice plans starting from January 1, 2001. SEC. 104. APPLICATION TO MEDICAID PROGRAM. Section 1902(a) of the Social Security Act is amended to require states to use generic forms of drugs in their Medicaid programs, unless specifically ordered by the provider or requested by the individual. This amendment applies to the program established under section 1927(g). The amendment made by this section applies to drugs furnished under State plans approved or renewed after the enactment of this Act. SEC. 105 of the Indian Health Care Improvement Act encourages the use of generic drugs by the Indian Health Service when providing health care items or services, unless the nongeneric form is specifically ordered by the provider or requested by the individual. This amendment applies to drugs furnished on or after the date of enactment of the Act. SEC. 106 encourages the use of generic drugs in veterans programs, providing a generic form unless specifically ordered by the provider or requested by the individual. SEC. 107 states that the amendments regarding the use of generic drugs shall apply to any drug provided after the enactment of the Act, including recipients of uniformed services health care. SEC. 107 encourages the use of generic drugs for recipients of uniformed services health care, unless specifically ordered by the prescribing provider or requested by the individual. SEC. 108. APPLICATION TO FEDERAL PRISONERS. The amendments made by this section apply to any drug provided on or after the enactment of this Act. The Attorney General must ensure that health care providers give generic drugs to prisoners charged with or convicted of a federal offense, unless the non-generic form is specifically ordered by the prescribing provider or requested by the prisoner. This amendment applies to drugs provided after the enactment of the Act. SEC. 201. THERAPEUTIC EQUIVALENCE OF GENERIC DRUGS. The amendment to Section 505(j) of the Federal Food, Drug, and Cosmetic Act focuses on determining the therapeutic equivalence of generic drugs to listed drugs based on active ingredients, dosage form, route of administration, strength, and standards. The amendment to Section 505(j) of the Federal Food, Drug, and Cosmetic Act emphasizes the therapeutic equivalence of generic drugs to listed drugs based on specific criteria. Generic drugs must meet standards regarding active ingredients, dosage form, route of administration, strength, and other factors to ensure clinical effectiveness and safety for patients. This supersedes any state laws related to determining therapeutic equivalence. The amendment to Section 505(j) of the Federal Food, Drug, and Cosmetic Act focuses on determining the therapeutic equivalence of generic drugs to listed drugs. The amendment requires the Secretary to include the official and proprietary names of therapeutically equivalent drugs in each revision of the list. The amendments made by this section will take effect on the date of enactment of the Act. The Senate suggests a preference for using generic pharmaceuticals in the Medicare program when adding a prescription drug benefit."
}